NASDAQ:EXPO - Exponent Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$56.45 +0.31 (+0.55 %)
(As of 04/19/2019 04:00 PM ET)
Previous Close$56.45
Today's Range$55.4350 - $56.56
52-Week Range$41.90 - $58.42
Volume189,412 shs
Average Volume198,712 shs
Market Capitalization$2.91 billion
P/E Ratio45.16
Dividend Yield1.14%
Beta0.47
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryResearch & Consulting Services
SectorBusiness Services
Current SymbolNASDAQ:EXPO
CUSIP30214U10
Phone650-326-9400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$379.52 million
Cash Flow$1.4306 per share
Book Value$6.04 per share

Profitability

Net Income$72.25 million

Miscellaneous

Employees1,122
Market Cap$2.91 billion
Next Earnings Date7/18/2019 (Estimated)
OptionableOptionable

Exponent (NASDAQ:EXPO) Frequently Asked Questions

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent announced a quarterly dividend on Friday, April 19th. Shareholders of record on Friday, June 7th will be paid a dividend of $0.16 per share on Friday, June 21st. This represents a $0.64 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Thursday, June 6th. View Exponent's Dividend History.

When did Exponent's stock split? How did Exponent's stock split work?

Shares of Exponent split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were distributed to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) released its earnings results on Thursday, April, 18th. The business services provider reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.07. The business services provider earned $93.40 million during the quarter, compared to analyst estimates of $93.52 million. Exponent had a net margin of 19.04% and a return on equity of 21.53%. The business's quarterly revenue was up 3.0% on a year-over-year basis. During the same period last year, the company earned $0.75 earnings per share. View Exponent's Earnings History.

When is Exponent's next earnings date?

Exponent is scheduled to release their next quarterly earnings announcement on Thursday, July 18th 2019. View Earnings Estimates for Exponent.

What price target have analysts set for EXPO?

3 brokerages have issued 1-year price targets for Exponent's stock. Their forecasts range from $56.00 to $56.00. On average, they anticipate Exponent's stock price to reach $56.00 in the next year. This suggests that the stock has a possible downside of 0.8%. View Analyst Price Targets for Exponent.

What is the consensus analysts' recommendation for Exponent?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exponent.

What are Wall Street analysts saying about Exponent stock?

Here are some recent quotes from research analysts about Exponent stock:
  • 1. According to Zacks Investment Research, "Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. " (4/2/2019)
  • 2. Cantor Fitzgerald analysts commented, ": We maintain our Overweight rating on Exponent and our PT of $56. We believe the nature of the company’s business gives Exponent an advantage in its ability to deliver results regardless of the economic backdrop. The company reported low-single-digit revenue growth for 4Q18, slightly below expectations. We expect revenues to grow in the mid-to-high single-digit range for all of 2019, with the opportunity for upside to conservative guidance, in our opinion, as we believe catalysts exist in a number of areas." (2/1/2019)

Has Exponent been receiving favorable news coverage?

News articles about EXPO stock have trended positive on Saturday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Exponent earned a daily sentiment score of 2.8 on InfoTrie's scale. They also gave press coverage about the business services provider a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the immediate future.

Who are some of Exponent's key competitors?

What other stocks do shareholders of Exponent own?

Who are Exponent's key executives?

Exponent's management team includes the folowing people:
  • Dr. Paul R. Johnston, Exec. Chairman (Age 65)
  • Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 50)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 53)
  • Dr. Bernard Ross, Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi, CTO & Principal Engineer (Age 72)

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (4.50%), Riverbridge Partners LLC (1.29%), Isthmus Partners LLC (0.19%), Louisiana State Employees Retirement System (0.04%), Strs Ohio (0.03%) and We Are One Seven LLC (0.01%). Company insiders that own Exponent stock include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss and Sally Shepard. View Institutional Ownership Trends for Exponent.

Which major investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC and Louisiana State Employees Retirement System. Company insiders that have sold Exponent company stock in the last year include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Richard L Schlenker Jr and Richard Reiss. View Insider Buying and Selling for Exponent.

Which major investors are buying Exponent stock?

EXPO stock was purchased by a variety of institutional investors in the last quarter, including Isthmus Partners LLC, Conestoga Capital Advisors LLC, Strs Ohio, Clarus Wealth Advisors and We Are One Seven LLC. View Insider Buying and Selling for Exponent.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $56.45.

How big of a company is Exponent?

Exponent has a market capitalization of $2.91 billion and generates $379.52 million in revenue each year. The business services provider earns $72.25 million in net income (profit) each year or $1.25 on an earnings per share basis. Exponent employs 1,122 workers across the globe.

What is Exponent's official website?

The official website for Exponent is http://www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]


MarketBeat Community Rating for Exponent (NASDAQ EXPO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  210 (Vote Outperform)
Underperform Votes:  209 (Vote Underperform)
Total Votes:  419
MarketBeat's community ratings are surveys of what our community members think about Exponent and other stocks. Vote "Outperform" if you believe EXPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/20/2019 by MarketBeat.com Staff

Featured Article: What Are Treasury Bonds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel